Israel Stocks: Clal Biotechnology and RadVision

(Corrects to say Avaya buying RadVision in fourth paragraph.)

Israel’s TA-25 Index (TA-25) dropped for second time this week, retreating 0.7 percent to 1,069.40 at 1:56 p.m. in Tel Aviv.

The following stocks rose or fell today. Symbols are in parenthesis.

Clal Biotechnology Industries Ltd. (CBI) fell to the lowest level since Nov. 21, dropping as much as 3.4 percent to 18.60 shekels ($4.9). The investor in biological companies said it will post a fourth-quarter loss of 20 million shekels after Eli Lilly & Co. (LLY) , in which it owns a 12 percent stake, ended a development agreement with TransPharma Medical Ltd.

RadVision Ltd. (RVSN) jumped as much as 15.5 percent to 36.36 shekels, the highest level since April. Avaya Inc. is in talks to buy the Israeli maker of video-conferencing systems for a premium, Globes and TheMarker reported, without saying where it got the information. The U.S. traded shares surged 15 percent yesterday to $9.72.

To contact the reporter on this story: {Sharon Wrobel} in Tel Aviv at

To contact the editor responsible for this story: Claudia Maedler at

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.